On May 28, 2020 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, reported it will host a conference call to review clinical updates and financial results for the three months ended March 31, 2020 on Monday, June 1, 2020 at 8:30 a.m. EDT (Press release, Can-Fite BioPharma, MAY 28, 2020, View Source [SID1234558599]). A press release reviewing the first quarter results and clinical updates will be issued prior to the call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors in the U.S. are invited to dial 877-423-9813. International investors may dial 201-689-8573. The conference ID is 13704594.

Investors may also participate via webcast: View Source

A replay of the webcast will be archived on Can-Fite’s website for a period of time.